Nicotinic receptor agonists for the treatment of inflammatory diseases
US7601720B2 · kind B2 · utility
1Cited by
8References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 25, 2002 |
| Grant date | Oct 13, 2009 |
| Priority date | — |
| Expiry date | Jan 3, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of nicotine receptor agonists for treating inflammatory diseases, including a variety of pulmonary diseases. Such agonists have fewer side effects than other anti-inflammatory drugs, such as steroids. Moreover, these agonists can be used alone or in combination with other anti-inflammatory drugs to alleviate pulmonary diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.